Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors.

Endoglin-mediated suppression of prostate cancer invasion is regulated by activin and bone morphogenetic protein type II receptors. PLoS One. 2013; 8(8):e72407.

View in: PubMed

subject areas

Activin Receptors, Type II
Activins
Antigens, CD
Bone Morphogenetic Protein Receptors, Type II
Cell Line, Tumor
Endoglin
Enzyme Activation
Humans
Male
Neoplasm Invasiveness
Prostatic Neoplasms
Protein Binding
Protein Interaction Domains and Motifs
Receptors, Cell Surface
Signal Transduction
Smad1 Protein

authors with profiles

Diarmuid M. Moran